Clinical Trial Update: Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports on a completed Phase 1/2 study evaluating positron emission tomography (PET) and magnetic resonance imaging (MRI) for pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-08-17